These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19932585)

  • 1. Increased CXCR4 expression in AsPC1 pancreatic carcinoma cells with RNA interference-mediated knockdown of DNMT1 and DNMT3B.
    Przybylski M; Kozłowska A; Pietkiewicz PP; Lutkowska A; Lianeri M; Jagodzinski PP
    Biomed Pharmacother; 2010 Apr; 64(4):254-8. PubMed ID: 19932585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA interference-mediated knockdown of DNMT1 and DNMT3B induces CXCL12 expression in MCF-7 breast cancer and AsPC1 pancreatic carcinoma cell lines.
    Sowińska A; Jagodzinski PP
    Cancer Lett; 2007 Sep; 255(1):153-9. PubMed ID: 17532557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of CXCR4 expression by tamoxifen is associated with DNA methyltransferase 3B up-regulation in MCF-7 breast cancer cells.
    Kubarek Ł; Kozłowska A; Przybylski M; Lianeri M; Jagodzinski PP
    Biomed Pharmacother; 2009 Sep; 63(8):586-91. PubMed ID: 19019622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double RNA interference of DNMT3b and DNMT1 enhances DNA demethylation and gene reactivation.
    Leu YW; Rahmatpanah F; Shi H; Wei SH; Liu JC; Yan PS; Huang TH
    Cancer Res; 2003 Oct; 63(19):6110-5. PubMed ID: 14559786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional analysis of CXCR4, DNMT3A, DNMT3B and DNMT1 gene expression in primary advanced uterine cervical carcinoma.
    Luczak MW; Roszak A; Pawlik P; Kędzia H; Kędzia W; Malkowska-Walczak B; Lianeri M; Jagodziński PP
    Int J Oncol; 2012 Mar; 40(3):860-6. PubMed ID: 21887463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of p53 represses E-cadherin expression by increasing DNA methyltransferase-1 and promoter methylation in serous borderline ovarian tumor cells.
    Cheng JC; Auersperg N; Leung PC
    Oncogene; 2011 Sep; 30(37):3930-42. PubMed ID: 21478913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of E-cadherin expression by K-Ras; involvement of DNA methyltransferase-3b.
    Kwon O; Jeong SJ; Kim SO; He L; Lee HG; Jang KL; Osada H; Jung M; Kim BY; Ahn JS
    Carcinogenesis; 2010 Jul; 31(7):1194-201. PubMed ID: 20375073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation.
    Chang HC; Cho CY; Hung WC
    Cancer Res; 2006 Sep; 66(17):8413-20. PubMed ID: 16951151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
    Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
    Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. XIST repression in the absence of DNMT1 and DNMT3B.
    Vasques LR; Stabellini R; Xue F; Tian XC; Soukoyan M; Pereira LV
    DNA Res; 2005; 12(5):373-8. PubMed ID: 16769694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antisense DNMT3b gene eukaryotic expression plasmid on expression of the DNMT3b gene in human biliary tract carcinoma cells.
    Zuo S; Dong JQ; Guo W; Liu MF; Xu LN; Luo J; Zou SQ
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):123-8. PubMed ID: 16481298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional activity of DNMT3B in pancreatic cancer cells: effects of -149 (C→T) promoter polymorphism.
    Xiao Y; Word B; Hammons G; Lyn-Cook B
    Biochem Biophys Res Commun; 2011 Nov; 415(2):220-3. PubMed ID: 21854760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methyltransferase 1 knockdown induces silenced CDH1 gene reexpression by demethylation of methylated CpG in hepatocellular carcinoma cell line SMMC-7721.
    Fan H; Zhao Z; Quan Y; Xu J; Zhang J; Xie W
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):952-61. PubMed ID: 18049164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNMT3A and DNMT3B mediate autocrine hGH repression of plakoglobin gene transcription and consequent phenotypic conversion of mammary carcinoma cells.
    Shafiei F; Rahnama F; Pawella L; Mitchell MD; Gluckman PD; Lobie PE
    Oncogene; 2008 Apr; 27(18):2602-12. PubMed ID: 17998942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of DNA methyltransferase 1 and/or DNA methyltransferase 3b mediates growth arrest and apoptosis in lung and esophageal cancer and malignant pleural mesothelioma cells.
    Kassis ES; Zhao M; Hong JA; Chen GA; Nguyen DM; Schrump DS
    J Thorac Cardiovasc Surg; 2006 Feb; 131(2):298-306. PubMed ID: 16434257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.
    Girault I; Tozlu S; Lidereau R; Bièche I
    Clin Cancer Res; 2003 Oct; 9(12):4415-22. PubMed ID: 14555514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.
    Reu FJ; Bae SI; Cherkassky L; Leaman DW; Lindner D; Beaulieu N; MacLeod AR; Borden EC
    J Clin Oncol; 2006 Aug; 24(23):3771-9. PubMed ID: 16801630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role of deltaDNMT3B4/2 in regulating RASSF1A promoter-specific DNA methylation in non-small cell lung cancer.
    Wang SH; Liu NH; Wang J; Bai H; Mao L
    Chin Med J (Engl); 2008 Sep; 121(17):1712-21. PubMed ID: 19024105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNMT3B gene amplification predicts resistance to DNA demethylating drugs.
    Simó-Riudalbas L; Melo SA; Esteller M
    Genes Chromosomes Cancer; 2011 Jul; 50(7):527-34. PubMed ID: 21484930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic regulation of X-linked cancer/germline antigen genes by DNMT1 and DNMT3b.
    James SR; Link PA; Karpf AR
    Oncogene; 2006 Nov; 25(52):6975-85. PubMed ID: 16715135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.